Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Umut Sarpel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4346-3641; OpenAlex author ID A5043235329. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: none · 2026: 2 papers

Papers 8

  1. Assessing Clinical Factors and Communication Barriers Impacting Postoperative Regret in Patients with Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18915-0↗
  2. ASO Visual Abstract: Assessing Clinical Factors and Communication Barriers Impacting Postoperative Regret in Patients with Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-19157-4↗
  3. Perineural Invasion of Pancreatic Ductal Adenocarcinoma is Associated with Early Recurrence after Neoadjuvant Therapy Followed by Resection. Co-author DOI 10.1007/s00268-023-06983-w↗
  4. Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreati… Co-author DOI 10.1245/s10434-023-13533-0↗
  5. Surgical management of pancreatic cancer liver oligometastases. Co-author DOI 10.1016/j.critrevonc.2022.103654↗
  6. Adjuvant Chemotherapy Is Not Guided by Pathologic Treatment Effect After Neoadjuvant Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001881↗
  7. Assessing the Implementation of American College of Surgeons Quality Indicators for Pancreatic Cancer Across an Integrated Health System. Last author DOI 10.1200/jop.18.00587↗
  8. Effect of intra-operative fluid volume on peri-operative outcomes after pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.22048↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Noah A. Cohen · 5 shared papers, 2021–2026 · strength 0.97
  2. Rebekah Macfie · 3 shared papers, 2022–2023 · strength 0.51
  3. Neha L. Lad · 2 shared papers, 2026 · strength 0.50
  4. Judy Li · 2 shared papers, 2026 · strength 0.50
  5. Camilo Correa‐Gallego · 2 shared papers, 2026 · strength 0.50
  6. Joshua Leinwand · 2 shared papers, 2026 · strength 0.50
  7. Elizabeth Gleeson · 2 shared papers, 2021–2023 · strength 0.30
  8. Celina Ang · 1 shared paper, 2023 · strength 0.17
  9. Noah A. Cohen · 1 shared paper, 2023 · strength 0.17
  10. Da Eun Cha · 1 shared paper, 2023 · strength 0.17
  11. Daniel Solomon · 1 shared paper, 2019 · strength 0.09
  12. Francesca Marcon · 1 shared paper, 2012 · strength 0.03
  13. Marcovalerio Melis · 1 shared paper, 2012 · strength 0.03
  14. Elliot Newman · 1 shared paper, 2012 · strength 0.03
  15. George Miller · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.